Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumors Harboring a BRAF V600 Mutation × ribociclib × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumors Harboring a BRAF V600 Mutation 1 Solid Tumors 1 Ovarian Neoplasms 1 Neoplasms 1 Mesothelioma 1 Lymphoma 1 Leukemia 1 Hematologic Neoplasms 1 Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies 1 Breast Neoplasms 1

Interventions

ribociclib 1 encorafenib 1 binimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01543698 2024-03-13

A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors

Pfizer

Phase 1/2 Completed

189 enrolled 44 charts

Other solid neoplasm

Solid Tumors Harboring a BRAF V600 Mutation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡